398 filings
Page 8 of 20
6-K
kyphq1p6m0
7 Aug 19
Acasti Pharma Schedules First Quarter Fiscal 2020 Conference Call
8:00am
F-3
71zh6hg154vp5fdl0ps
7 Aug 19
Shelf registration (foreign)
12:00am
6-K
dk05icnh
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
vdx5bjtn7bmr
25 Jul 19
Current report (foreign)
3:56pm
EFFECT
4zsjliwfl
18 Jul 19
Notice of effectiveness
12:15am
POS AM
u7rr5ns81 2cr
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
nyx2 vb7tx4pcq9p6
5 Jul 19
Current report (foreign)
9:00am
6-K
jzix04
26 Jun 19
Acasti Pharma Provides Fiscal 2019 Year-End Business Update
8:06am
6-K
crs5h
24 Jun 19
Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition
9:01am
6-K
hsecpq2zq
19 Jun 19
Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call
8:00am
6-K
p23wxf73 di4x
4 Jun 19
Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia
9:15am
6-K
dzpog86hgf0p vxx5
21 May 19
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
7:31am
6-K
ksmgdlo
15 May 19
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel
7:56am
6-K
xt8d8rbw4n5
10 May 19
Current report (foreign)
10:05am
6-K
ldjt2q k3hltewia
24 Apr 19
Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City
8:35am
6-K
pvcbdxyvodq2 z5gi
15 Apr 19
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
9:15am
6-K
uzr5oj3k2jzt1a 2zy
26 Mar 19
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
8:30am
6-K
34fgwu 7i4p7obrz
13 Mar 19
Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th
8:30am
6-K
yfobo9257euvibx 3v
21 Feb 19
Current report (foreign)
9:15am